The pharmacological inhibition of APN/CD13 by bestatin caused CDDP-resistant gastric cancer cells to become sensitive to CDDP and was able to inhibit epithelial-to-mesenchymal transition (EMT), migration, and invasion [80]. The gene discussed is ANPEP; the disease is gastric cancer.